Novozymes A/S (NVZMF) Stock Price, News & Analysis

Company Overview

Novozymes A/S was a Denmark-based biotechnology company specializing in enzymes, microorganisms and other biological solutions. Its products were designed to improve industrial processes and support more sustainable production across areas including food and beverages, household care, agriculture, bioenergy and technical applications.

The company developed and commercialized biological products used in applications such as baking, brewing, animal nutrition, crop production, laundry and cleaning, textiles, biofuels and wastewater treatment. Novozymes served customers in markets worldwide through research, manufacturing and commercial operations spanning Europe, North America, Asia and other international regions.

Novozymes was established in 2000 through the separation of the enzyme and microorganism business from Novo Nordisk. Ester Baiget served as the company’s president and chief executive officer during its final standalone years. In 2024, Novozymes combined with Chr. Hansen Holding A/S to form Novonesis, a biosolutions company focused on combining enzyme, microbial and related biological technologies.

Key Stats

• Today's Range: $65.35 to $65.35
• 50-Day Range: $62.68 to $71.12
• 52-Week Range: $52.10 to $72.98
• Volume: 100 shs
• Average Volume: 1,438 shs
• Market Capitalization: N/A
• P/E Ratio: 8.15
• Dividend Yield: 2.75%
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 4/20/2016
• Today: 10/14/2026
• Next Earnings (Estimated): 11/05/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Materials
• Industry: Chemicals
• Sub-Industry: Specialty Chemicals
• Current Symbol: OTCMKTS:NVZMF
• CIK: 1131345
• Web: www.novonesis.com
• Phone: (454) 446-0000
• Fax: N/A
• Employees: 11,641
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 8.15
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A